Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study
Copyright © 2017 Steens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. We investigated the safety and antiviral effects of an anti-HIV compound (ABX464) with a unique mechanism of viral replication inhibition. This was...
Saved in:
Main Authors: | Jean Marc Steens, Didier Scherrer, Paul Gineste, P. Noel Barrett, Supparatpino Khuanchai, Ratanasuwan Winai, Kiat Ruxrungtham, Jamal Tazi, Robert Murphy, Hartmut Ehrlich |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021658372&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/57674 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study
by: Jean Marc Steens, et al.
Published: (2018) -
Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study
by: Steens J., et al.
Published: (2017) -
Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
by: Sawitree Nangola, et al.
Published: (2018) -
Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
by: Nangola S., et al.
Published: (2014) -
Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions
by: Sudarat Hadpech, et al.
Published: (2022)